NCT04031677

Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma

RecruitingPHASE3INTERVENTIONAL

Trial Details

Start: 2021-01-20Est. Completion: 2027-04-21

Enrollment target: 250 participants

Locations

University of Alabama at Birmingham Cancer Center, Birmingham, Alabama, United States
Mayo Clinic Hospital in Arizona, Phoenix, Arizona, United States
City of Hope Comprehensive Cancer Center, Duarte, California, United States
UCI Health-Chao Family Comp CC and Ambulatory Care, Irvine, California, United States
UC San Diego Moores Cancer Center, La Jolla, California, United States
UC Irvine Health/Chao Family Comprehensive Ca Ctr, Orange, California, United States
UCHealth University of Colorado Hospital, Aurora, Colorado, United States
Smilow Cancer Hospital-Derby Care Center, Derby, Connecticut, United States
Smilow Cancer Hospital Care Center-Fairfield, Fairfield, Connecticut, United States
Smilow Cancer Hospital Care Center at Glastonbury, Glastonbury, Connecticut, United States
Smilow Cancer Hospital Care Center at Greenwich, Greenwich, Connecticut, United States
Smilow Cancer Hospital Care Center - Guiford, Guilford, Connecticut, United States
Smilow Cancer Hospital Care Ctr at Saint Francis, Hartford, Connecticut, United States
Yale University, New Haven, Connecticut, United States

Soft Tissue Sarcoma

The purpose of this study is to examine the safety and efficacy of an abbreviated course of preoperative radiation, give…

Palo Alto, United StatesEst. completion Dec 2027

Retroperitoneal SarcomaLiposarcomaDedifferentiated Liposarcoma

This phase I trial tests the safety, side effects, and best dose of abemaciclib and how well it works with radiation the…

Seattle, United StatesEst. completion Mar 3, 2027

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.